Skip to main content
Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression

Fig. 1

Plasma NfL and p-tau181 levels in the cohort. Boxplots of plasma NfL (a) and p-tau181 (b) concentrations in cognitively healthy participants (CN) and patients with cognitive impairment (CI). Both groups were further stratified according to AD CSF biomarker profile. Mean concentrations between pairs of groups were compared using T-tests. *, p-value < 0.05; ***, p-value < 0.001

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193